794 related articles for article (PubMed ID: 15456268)
1. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
5. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
6. Pyrimido[4,5,6-kl]acridines. Synthesis, in vitro cytotoxicity and structure-activity relationships.
Antonini I; Polucci P; Martelli S
Anticancer Drug Des; 1999 Oct; 14(5):451-9. PubMed ID: 10766300
[TBL] [Abstract][Full Text] [Related]
7. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
Antonini I
Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.
Antonini I; Polucci P; Magnano A; Martelli S
J Med Chem; 2001 Sep; 44(20):3329-33. PubMed ID: 11563932
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
10. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
[TBL] [Abstract][Full Text] [Related]
11. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of phenanthrene-derived carboxamides as cytotoxic agents.
Cherubim P; Deady LW; Dorkos M; Quazi NH; Baguley BC; Denny WA
Anticancer Drug Des; 1993 Dec; 8(6):429-38. PubMed ID: 8286011
[TBL] [Abstract][Full Text] [Related]
13. 2,6-Di(omega-aminoalkyl)-2,5,6,7-tetrahydropyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine-5,7-diones: novel, potent, cytotoxic, and DNA-binding agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2002 Jan; 45(3):696-702. PubMed ID: 11806721
[TBL] [Abstract][Full Text] [Related]
14. Pyrimidoacridine derivatives as potential antitumor agents.
Antonini I; Cola D; Martelli S; Cholody WM; Konopa J
Farmaco; 1992; 47(7-8):1035-46. PubMed ID: 1445611
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines.
Li J; Zhao YF; Zhao XL; Yuan XY; Gong P
Arch Pharm (Weinheim); 2006 Nov; 339(11):593-7. PubMed ID: 17036367
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
17. Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells.
Carraro F; Pucci A; Naldini A; Schenone S; Bruno O; Ranise A; Bondavalli F; Brullo C; Fossa P; Menozzi G; Mosti L; Manetti F; Botta M
J Med Chem; 2004 Mar; 47(7):1595-8. PubMed ID: 15027847
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
19. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
20. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
